Patrick Schnider

1.7k total citations
20 papers, 1.4k citations indexed

About

Patrick Schnider is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Patrick Schnider has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Patrick Schnider's work include Asymmetric Hydrogenation and Catalysis (6 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Patrick Schnider is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (6 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Patrick Schnider collaborates with scholars based in Switzerland, Germany and United States. Patrick Schnider's co-authors include Andreas Pfaltz, Andrew P. Lightfoot, Guido Koch, Roger Prétôt, Patrizio Mattei, Carl Krüger, Guozhi Wang, F.M. Bohnen, Jens‐Uwe Peters and Manfred Kansy and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Patrick Schnider

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Schnider Switzerland	12	954	942	438	311	112	20	1.4k
Andrew P. Lightfoot United Kingdom	19	890 0.9×	1.2k 1.2×	385 0.9×	282 0.9×	93 0.8×	28	1.5k
Mark Rogers‐Evans Switzerland	20	150 0.2×	1.5k 1.5×	676 1.5×	48 0.2×	64 0.6×	35	2.0k
Laurent Bischoff France	19	222 0.2×	823 0.9×	355 0.8×	88 0.3×	42 0.4×	61	1.2k
Shau‐Hua Ueng Taiwan	21	318 0.3×	1.5k 1.6×	511 1.2×	73 0.2×	48 0.4×	36	2.0k
Brian C. Shook United States	18	347 0.4×	1.5k 1.6×	509 1.2×	81 0.3×	48 0.4×	25	2.1k
Shainaz M. Landge United States	17	150 0.2×	577 0.6×	181 0.4×	42 0.1×	23 0.2×	38	910
Eunsuk Kim United States	23	693 0.7×	375 0.4×	359 0.8×	62 0.2×	25 0.2×	42	1.4k
Christophe Génicot Belgium	24	390 0.4×	1.6k 1.7×	399 0.9×	71 0.2×	44 0.4×	39	2.4k
Erin F. DiMauro United States	20	302 0.3×	759 0.8×	409 0.9×	18 0.1×	40 0.4×	40	1.2k
Michael T. Scerba United States	18	304 0.3×	871 0.9×	298 0.7×	37 0.1×	26 0.2×	36	1.5k

Countries citing papers authored by Patrick Schnider

Since Specialization

Citations

This map shows the geographic impact of Patrick Schnider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Schnider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Schnider more than expected).

Fields of papers citing papers by Patrick Schnider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Schnider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Schnider. The network helps show where Patrick Schnider may publish in the future.

Co-authorship network of co-authors of Patrick Schnider

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Schnider. A scholar is included among the top collaborators of Patrick Schnider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Schnider. Patrick Schnider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janz, Philipp, Frédéric Knoflach, Konrad Bleicher, et al.. (2023). Selective oxytocin receptor activation prevents prefrontal circuit dysfunction and social behavioral alterations in response to chronic prefrontal cortex activation in male rats. Frontiers in Cellular Neuroscience. 17. 1 indexed citations

Weber, Michaël, Jean‐Yves Wach, Anja Gundlfinger, et al.. (2023). Selective and brain-penetrant HCN1 inhibitors reveal links between synaptic integration, cortical function, and working memory. Cell chemical biology. 31(3). 577–592.e23. 8 indexed citations

Schnider, Patrick, Caterina Bissantz, Andreas Bruns, et al.. (2020). Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder. Journal of Medicinal Chemistry. 63(4). 1511–1525. 39 indexed citations

Schnider, Patrick, Henri Stalder, Rainer E. Martin, et al.. (2019). Modulation of Pharmacologically Relevant Properties of Piperidine Derivatives by Functional Groups in an Equatorial or Axial β‐Position to the Amino Group. ChemBioChem. 21(1-2). 212–234. 8 indexed citations

Nederpelt, Indira, Maria Kuzikov, Wilhelmus E. A. de Witte, et al.. (2017). From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action. Scientific Reports. 7(1). 14169–14169. 8 indexed citations

Ratni, Hasane, Mark Rogers‐Evans, Caterina Bissantz, et al.. (2015). Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach. Journal of Medicinal Chemistry. 58(5). 2275–2289. 40 indexed citations

Bissantz, Caterina, et al.. (2012). Identification of a Crucial Amino Acid in the Helix Position 6.51 of Human Tachykinin Neurokinin 1 and 3 Receptors Contributing to the Insurmountable Mode of Antagonism by Dual NK₁/NK₃Antagonists. Journal of Medicinal Chemistry. 55(11). 5061–5076. 5 indexed citations

Mayweg, A., Urs Hofer, Patrick Schnider, et al.. (2011). ROCK: the Roche medicinal chemistry knowledge application – design, use and impact. Drug Discovery Today. 16(15-16). 691–696. 15 indexed citations

Malherbe, Pari, Frédéric Knoflach, T. Hoffmann, et al.. (2010). Characterization of RO4583298 as a novel potent, dual antagonist within vivoactivity at tachykinin NK₁and NK₃receptors. British Journal of Pharmacology. 162(4). 929–946. 11 indexed citations

10.

Peters, Jens‐Uwe, Torsten Hoffmann, Patrick Schnider, et al.. (2010). Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(11). 3405–3408. 12 indexed citations

11.

Malherbe, Pari, Frédéric Knoflach, Lucinda J. Steward, et al.. (2010). CHARACTERIZATION OF RO4583298 AS A HIGHLY POTENT, DUAL ANTAGONIST WITH IN VIVO ACTIVITY AT TACHYKININ NK1 AND NK3 RECEPTORS. Schizophrenia Research. 117(2-3). 485–486. 1 indexed citations

12.

Peters, Jens‐Uwe, Patrick Schnider, Patrizio Mattei, & Manfred Kansy. (2009). Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds. ChemMedChem. 4(4). 680–686. 109 indexed citations

13.

Hoffmann, Torsten, Michael Bös, Heinz Stadler, et al.. (2005). Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(5). 1362–1365. 34 indexed citations

14.

Myers, Andrew G., Patrick Schnider, Soojin Kwon, & Daniel W. Kung. (1999). Greatly Simplified Procedures for the Synthesis of α-Amino Acids by the Direct Alkylation of Pseudoephedrine Glycinamide Hydrate. The Journal of Organic Chemistry. 64(9). 3322–3327. 58 indexed citations

15.

Lightfoot, Andrew P., Patrick Schnider, & Andreas Pfaltz. (1998). Enantioselective Hydrogenation of Olefins with Iridium-Phosphanodihydrooxazole Catalysts. Angewandte Chemie International Edition. 37(20). 2897–2899. 366 indexed citations

16.

Lightfoot, Andrew P., Patrick Schnider, & Andreas Pfaltz. (1998). Enantioselective Hydrogenation of Olefins with Iridium–Phosphanodihydrooxazole Catalysts. Angewandte Chemie International Edition. 37(20). 2897–2899. 326 indexed citations

17.

Lightfoot, Andrew P., Patrick Schnider, & Andreas Pfaltz. (1998). Enantioselektive Hydrierung von Olefinen mit Phosphandihydrooxazol-Iridium-Katalysatoren. Angewandte Chemie. 110(20). 3047–3050. 126 indexed citations

18.

Schnider, Patrick, Guido Koch, Roger Prétôt, et al.. (1997). Enantioselective Hydrogenation of Imines with Chiral (Phosphanodihydrooxazole)iridium Catalysts. Chemistry - A European Journal. 3(6). 887–892. 202 indexed citations

19.

Schnider, Patrick, Guido Koch, Roger Prétôt, et al.. (1997). ChemInform Abstract: Enantioselective Hydrogenation of Imines with Chiral ( Phosphanodihydrooxazole)iridium Catalysts.. ChemInform. 28(36). 1 indexed citations

20.

Koch, Guido, Guy C. Lloyd‐Jones, Olivier Loiseleur, et al.. (1995). Synthesis of chiral (phosphinoaryl)oxazolines, a versatile class of ligands for asymmetric catalysis. Recueil des Travaux Chimiques des Pays-Bas. 114(4-5). 206–210. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact